Cardio Diagnostics Holdings, Inc. (CDIOW)

NASDAQ • Currency in USD

$484.00

+$8.92

+1.88%

Last Update: 18 Jul 2026, 12:41

$847.69m

Market Cap

-143.20

P/E Ratio (TTM)

—

Forward Dividend Yield

$351.00-$647.45

52 Week Range

CDIOW Stock Price Chart

Explore Cardio Diagnostics Holdings, Inc. interactive price chart. Choose custom timeframes to analyze CDIOW price movements and trends.

CDIOW Company Profile

Discover essential business fundamentals and corporate details for Cardio Diagnostics Holdings, Inc. (CDIOW) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

14 Jan 2022

Employees

13.00

Website

https://cardiodiagnosticsinc.com

CEO

Meeshanthini V. Dogan

Description

Founded in Chicago, Illinois, in 2017, Cardio Diagnostics Holdings, Inc. specializes in the creation and market introduction of clinical tests. These diagnostic tools leverage epigenetics to assess cardiovascular disease risk. Among its offerings is Epi+Gen CHD, a test designed to predict the risk of symptomatic coronary heart disease over a three-year timeframe.

CDIOW Financial Timeline

Browse a chronological timeline of Cardio Diagnostics Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 2 Sept 2026

Earnings released on 13 Mar 2026

EPS came in at -$0.80 surpassing the estimated -$1.80 by +55.56%, while revenue for the quarter reached $3.56k , missing expectations by -98.58%.

Earnings released on 12 Nov 2025

EPS came in at -$0.98 surpassing the estimated -$1.80 by +45.82%, while revenue for the quarter reached $2.86k , missing expectations by -98.10%.

Earnings released on 14 Aug 2025

EPS came in at -$0.97 surpassing the estimated -$1.80 by +46.23%, while revenue for the quarter reached $7.48k , missing expectations by -90.03%.

Earnings released on 15 May 2025

EPS came in at -$0.97 surpassing the estimated -$1.80 by +46.13%, while revenue for the quarter reached $940.00 , missing expectations by -98.12%.

CDIOW Stock Performance

Access detailed CDIOW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.